Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine for Postoperative Opioid Reduction in Gynecological Surgery
NCT07528651Completed
- Sponsor
- Erasmus Hospital
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of esketamine in postoperative pain (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Postoperative opioid consumption at 24 hours. Started Jun 2021; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07528651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07528651.